FR2953103A1 - Metabolism modifying nutritional supplement, useful in the formulation of e.g. gel capsules, tablets, lozenges, gels, and granules, comprises powder of Lycium barbarum and Lycium chinense berry coating microgranules of marine aragonite - Google Patents
Metabolism modifying nutritional supplement, useful in the formulation of e.g. gel capsules, tablets, lozenges, gels, and granules, comprises powder of Lycium barbarum and Lycium chinense berry coating microgranules of marine aragonite Download PDFInfo
- Publication number
- FR2953103A1 FR2953103A1 FR0905770A FR0905770A FR2953103A1 FR 2953103 A1 FR2953103 A1 FR 2953103A1 FR 0905770 A FR0905770 A FR 0905770A FR 0905770 A FR0905770 A FR 0905770A FR 2953103 A1 FR2953103 A1 FR 2953103A1
- Authority
- FR
- France
- Prior art keywords
- nutritional supplement
- powder
- lycium
- supplement according
- microgranules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 27
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title claims abstract description 9
- 244000241838 Lycium barbarum Species 0.000 title claims description 10
- 235000015459 Lycium barbarum Nutrition 0.000 title claims description 10
- 244000241872 Lycium chinense Species 0.000 title claims description 10
- 235000015468 Lycium chinense Nutrition 0.000 title claims description 10
- 235000021028 berry Nutrition 0.000 title claims description 10
- 239000008187 granular material Substances 0.000 title claims description 7
- 239000002775 capsule Substances 0.000 title claims description 6
- 239000000203 mixture Substances 0.000 title claims description 5
- 239000003826 tablet Substances 0.000 title claims description 5
- 239000000499 gel Substances 0.000 title claims description 4
- 238000009472 formulation Methods 0.000 title claims 2
- 239000011248 coating agent Substances 0.000 title abstract description 3
- 238000000576 coating method Methods 0.000 title abstract description 3
- 230000004060 metabolic process Effects 0.000 title abstract 2
- 239000007937 lozenge Substances 0.000 title 1
- 240000003394 Malpighia glabra Species 0.000 claims description 6
- 235000014837 Malpighia glabra Nutrition 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 240000002900 Arthrospira platensis Species 0.000 claims description 4
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 4
- 241001490476 Pinctada maxima Species 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
- 229940082787 spirulina Drugs 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 3
- 244000163122 Curcuma domestica Species 0.000 claims description 3
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 235000003373 curcuma longa Nutrition 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 235000013976 turmeric Nutrition 0.000 claims description 3
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 2
- 240000006162 Chenopodium quinoa Species 0.000 claims description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
- 241000340987 Ptychopetalum olacoides Species 0.000 claims description 2
- 241001400590 Richia Species 0.000 claims description 2
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229960001948 caffeine Drugs 0.000 claims description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000006041 probiotic Substances 0.000 claims description 2
- 235000018291 probiotics Nutrition 0.000 claims description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 2
- 239000011859 microparticle Substances 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 1
- 230000000050 nutritive effect Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 241001106041 Lycium Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000000855 fungicidal effect Effects 0.000 abstract 1
- 239000000417 fungicide Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 241000237852 Mollusca Species 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011785 micronutrient Substances 0.000 description 3
- 235000013369 micronutrients Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- -1 beta-systemol Natural products 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229940015412 caffeine 25 mg Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical class NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 1
- KUFXJZXMWHNCEH-UHFFFAOYSA-N cyperone Natural products C1CC(=O)C(C)=C2CC(C(=C)C)CCC21C KUFXJZXMWHNCEH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Complément nutritif modificateur de terrain contenant de la 5 poudre de baies de Lycium barbarum et de Lycium chinense enrobant des microgranules d'aragonite marine 10 Les dysfonctionnements de la plupart des organes et systèmes sont souvent liés à des maladies génétiques et à des agressions microbiennes avec pour corollaire l'absence ou l'insuffisance de production de certaines protéines et d'autres substances qui jouent un rôle essentiel dans le métabolisme 15 cellulaire. D'autres dysfonctionnements sont liés à un apport insuffisant d'acides aminés, de protéines, d'oligo-éléments, de vitamines et d'autres nutriments indispensables au bon fonctionnement cellulaire et tissulaire. C'est pourquoi l'identification des molécules actives contenues dans les microgranules 20 d'aragonite marine et dans les baies de Lycium barbarum et de Lycium chinense nous ont amenés à en proposer l'utilisation en nutrithérapie avec comme objectif l'amélioration du fonctionnement des organes et systèmes. Les microgranules sont obtenus à partir de la coquille interne ou test nacré de mollusques géants tels que Pinctada Maxima, par concassage et 25 tamisage après un traitement décontaminant. Le procédé de fabrication consiste après lavage, à la décontamination à l'aide d'une solution désinfectante composée d' hypochlorite de sodium à 2% et d'eau déminéralisée; Les coquilles sont rincées à l'aide d'un flux d'eau courante à 70°C puis séchées. Elles sont ensuite broyées à l'aide d'un concasseur pour minéraux de type Fristch par plusieurs 30 rotations de broyage jusqu'à obtention de particules microscopiques de dimensions aléatoires. Le résultat est recueilli et placé dans une tamiseuse de type Fristch comportant deux tamis, l'un de 75 microns et l'autre de 70 microns et un fond de collecte. Après tamisage les particules contenues dans le fond de collecte et le tamis de 70 microns sont recueillies et placées dans un tambour 35 tournant sur un axe horizontal alternativement dans les deux sens à une vitesse de 50 tours minute pendant deux heures. Cette étape est indispensable à l'obtention de microgranules de forme sphérique. En effet lors du broyage les grains obtenus ne sont pas uniformes, les frottements des particules entre elles lors des rotations du tambour, arrondissent les angles et les arrêtes,leur donnant 40 une forme sphérique; cette forme favorisant l'action des sucs digestifs. Field-modifying nutrient supplement containing Lycium barbarum and Lycium chinense berry powder coated with marine aragonite microgranules The dysfunctions of most organs and systems are often related to genetic diseases and microbial aggression with This leads to the absence or insufficiency of production of certain proteins and other substances which play an essential role in cellular metabolism. Other dysfunctions are linked to insufficient intake of amino acids, proteins, trace elements, vitamins and other nutrients essential for proper cell and tissue function. This is why the identification of the active molecules contained in the microgranules of marine aragonite and in the berries of Lycium barbarum and Lycium chinense have led us to propose its use in nutritherapy with the objective of improving the functioning of organs and systems. The microgranules are obtained from the inner shell or pearlescent test of giant molluscs such as Pinctada Maxima, by crushing and sieving after a decontaminating treatment. The manufacturing process consists after washing, decontamination with a disinfectant solution composed of 2% sodium hypochlorite and demineralised water; The shells are rinsed with a stream of running water at 70 ° C and dried. They are then milled using a Fristch-type mineral crusher by several milling rotations until microscopic particles of random size are obtained. The result is collected and placed in a Fristch sieve with two sieves, one of 75 microns and the other of 70 microns and a collection bottom. After sieving the particles contained in the collection bottom and the 70 micron sieve are collected and placed in a drum rotating on a horizontal axis alternately in both directions at a speed of 50 rpm for two hours. This step is essential to obtain spherical microgranules. Indeed, during grinding the grains obtained are not uniform, the friction of the particles together during rotations of the drum, round the corners and edges, giving them a spherical shape; this form promotes the action of digestive juices.
On sait que l'aragonite de certains mollusques géants tels que la Pinctada Maxima contient la plupart des acides aminés majoritaires, des protéines, des glycoprotéines, des protéoglycanes et autres micronutriments indispensables au métabolisme cellulaire. On a isolé de l'aragonite de ces mollusques; de la valine, de la leucine, de l'isoleucine qui sont des acides aminés essentiels qui ne peuvent être synthétisés par l'organisme humain,-l'arginine, l'acide glutamique qui ont des propriétés inhibitrices des radicaux litres, -de l'acide aspartique et de l'acide glutamique qui par réactions biochimiques se transforment en certains métabolites intervenant dans le cycle de Krebs, -de la glycine qui possède des propriétés anti-asthéniques et agit comme tampon biologique et donne par perméthylation, naissance à la bétaïne impliquée dans le transfert intramitochondrial des acides gras et est présent dans le tissu musculaire sous forme de phosphagène, réserve d'énergie capitale pour la contraction musculaire à travers l'un de ses dérivés la créatine. Sont également présents dans la nacre :la thréonine qui permet au foie de stocker le glycogène qui est une réserve de sucre, -la proline qui est un constituant principal du collagène, -la tyrosine amino-acide précurseur des mélanines et des cathécholamines, et qui donne par oxydation ,de la dopa, qui, par décarboxylation conduit à la dopamine, neuro transmetteur jouant un rôle important dans le fonctionnement du cerveau,-la tyrosine qui est aussi le précurseur des hormones thyroïdiennes. la phényalanine qui est un acide aminé indispensable, précurseur de la tyrosine obtenue par oxydation, -l'histidine qui intervient dans de nombreuses réactions biochimiques comme médiateur et donne naissance à l'histamine par décarboxydalation, la méthionine qui intervient dans la biosynthèse de nombreuses substances biologiques comme l'adrénaline et qui joue un rôle métabolique indispensable. Aragonite of some giant molluscs such as Pinctada Maxima are known to contain most of the major amino acids, proteins, glycoproteins, proteoglycans and other micronutrients that are essential for cellular metabolism. Aragonite has been isolated from these molluscs; valine, leucine, isoleucine which are essential amino acids which can not be synthesized by the human body, arginine, glutamic acid which have inhibitory properties of the literal radicals, Aspartic acid and glutamic acid which by biochemical reactions are transformed into certain metabolites involved in the Krebs cycle, glycine which has anti-asthenic properties and acts as a biological buffer and gives by permethylation, birth to betaine implicated in the intramitochondrial transfer of fatty acids and is present in muscle tissue in the form of phosphagen, a vital energy reserve for muscle contraction through one of its creatine derivatives. Also present in the mother-of-pearl is threonine, which allows the liver to store glycogen, which is a reserve of sugar, proline, which is a principal constituent of collagen, the amino acid tyrosine precursor of melanins and cathecholamines, and gives by oxidation, dopa, which by decarboxylation leads to dopamine, a neurotransmitter playing an important role in the functioning of the brain, tyrosine which is also the precursor of thyroid hormones. Phenylalanine, which is an essential amino acid, a precursor of tyrosine obtained by oxidation, Histidine, which mediates numerous biochemical reactions and gives rise to histamine by decarboxydalation, the methionine which is involved in the biosynthesis of many substances. like adrenaline and plays an essential metabolic role.
La cystéine constituant important de la kératine, possède des propriétés bioénergétiques, -l'alanine qui associée à des protéines ou à l'état libre est présente dans tous les milieux biologiques. Concernant les oligo-éléments présents dans les microgranules, on sait que le fer est présent dans tous les systèmes métabolique et dans les enzymes respiratoires. Cysteine, an important constituent of keratin, has bioenergetic properties, alanine which is associated with proteins or in the free state is present in all biological media. Regarding micronutrients present in the microgranules, iron is known to be present in all metabolic systems and in respiratory enzymes.
Le brome possède des propriétés sédatives, -le manganèse, inhibe la libération des médiateurs chimiques impliqués dans les allergies, -le sodium joue un rôle important dans l'équilibre biologique,-le potassium,-le soufre jouent un rôle biocatalytique, -le zinc est présent dans les leucocytes, les enzymes et joue un rôle important dans la biosynthèse des protéines, dans les procésus de reproduction et de croissance, dans la résistance aux infections et dans l'immuno-stimulation et enfin dans la production du flux salivaire. -Le cuivre possède des propriétés antibactériennes, antifongiques et anti inflammatoires. Bromine has sedative properties, - manganese, inhibits the release of chemical mediators involved in allergies, - sodium plays an important role in biological balance, - potassium, - sulfur play a biocatalytic role, - zinc is present in leukocytes, enzymes, and plays an important role in protein biosynthesis, reproductive and growth processes, infection resistance and immunostimulation, and salivary flow production. Copper has antibacterial, antifungal and anti-inflammatory properties.
Le produit selon l'invention est mélangé à de la poudre de baies de Lycium barbarum et de Lycium chinense selon le mode de préparation suivant: La poudre est versée dans le tambour contenant les microgranules de nacre pendant la rotation. Les fines particules de poudre adhèrent aux micro granules de nacre en enrobant leur surface. The product according to the invention is mixed with Lycium barbarum berry powder and Lycium chinense according to the following method of preparation: The powder is poured into the drum containing the mother-of-pearl microgranules during the rotation. The fine particles of powder adhere to the mother-of-pearl micro-granules by coating their surface.
On obtient des granules organo-minéro-végétales dont le noyau est constitué d'aragonite marine et la croûte de poudre de baies de Lycium barbarum et Lycium chinense agglomérée et c'est ce qui devient le produit selon l'invention. Celui-ci est mélangé à d'autres substances biologiques et entre dans la composition de compléments nutritifs modificateurs de terrain. Organo-mineral-vegetable granules are obtained, the core of which consists of marine aragonite and the crust of Lycium barbarum and Lycium chinense agglomerated berry powder, and this is what becomes the product according to the invention. This is mixed with other biological substances and is included in the composition of field-modifying nutrient supplements.
La présence de poudre de baies séchées de Lycium barbarum et Lycium chinense se justifie par la quasi similitude de sa composition avec celle de l'aragonite marine des granules. En effet outre les 19 acides aminés, les électrolytes, les oligo-éléments, les caroténoïdes, les polysaccharides, les baies de Lycium barbarum et Lycium chinense contiennent d'importantes quantités de germanium organique qui possède des propriétés immunostimulantes remarquables, des propriétés antioxydantes et surtout une fonction principale qui est de favoriser l'oxygénation des cellules, -de la vitamine C, -des vitamines du groupe B (Riboflavine Niacine), -de vitamine E, -des acides gras essentiels poly-insaturés (oméga 3, oméga 6), -des micro nutriments tels la taurine, la bétaïne, le béta systérol, la cypérone et la physaline Les constituants des microgranules et des baies de Lycium barbarum et Lycium chinense agissent en synergie et confèrent à l'ensemble des propriétés anti oxydantes et énergisantes exceptionnelles. Selon un mode de réalisation préférentiel, le produit selon l'invention peut être associé à d'autres substances telles la spiruline, l'acérola, la poudre de quinoa, de guarana, de poudre de feuilles de maté, le thé vert, la caféine, le gingembre, des probiotiques tel que lactobacillus plantarum, lactobacillus acidophyllus et bifido bactérium, des composés vitaminiques organiques, le curcuma ou toutes autres substances biologiques toutes les fois où on désire lui conférer des propriétés spécifiques. C'est ainsi que le produit selon l'invention entre dans la composition de gélules, de capsules, de comprimés, de tablettes, de gels, de solutions aqueuses, de granules dont la formule, sans que l'exemple soit limitatif, est pour une gélule de 300 mg.40 Exemple 1 : - microgranules enrobés 200 mg - poudre d'acérola 50 mg - poudre spiruline 25 mg - caféine 25 mg - microgranules enrobés 200 mg - poudre d'acérola 50 mg - poudre de racine de Muira puama 20 mg - poudre de thé vert 30 mg - microgranules enrobés 200 mg - poudre d'écorce de Richéria grandis 50 mg - curcuma 25 mg - gingembre 25 mg 25 Exemple 4 : - microgranules enrobés 200 mg - poudre d'acérola 50 mg - lactobacillus plantarum 15 mg - lactobacillus acodiphyllus 20 mg 30 - bifido bactérium 15 mg The presence of dried berry powder of Lycium barbarum and Lycium chinense is justified by the near similarity of its composition with that of the marine aragonite granules. In addition to the 19 amino acids, electrolytes, trace elements, carotenoids, polysaccharides, Lycium barbarum and Lycium chinense berries contain significant amounts of organic germanium which has remarkable immunostimulatory properties, antioxidant properties and above all a main function which is to promote the oxygenation of cells, vitamin C, vitamins of group B (Riboflavin Niacin), vitamin E, polyunsaturated essential fatty acids (omega 3, omega 6) , micro-nutrients such as taurine, betaine, beta-systemol, cyperone and physaline The constituents of the microgranules and berries of Lycium barbarum and Lycium chinense act in synergy and give all the exceptional antioxidant and energizing properties . According to a preferred embodiment, the product according to the invention can be combined with other substances such as spirulina, acerola, quinoa powder, guarana powder, mate leaf powder, green tea, caffeine. , ginger, probiotics such as lactobacillus plantarum, lactobacillus acidophyllus and bifido bacterium, organic vitamin compounds, turmeric or any other biological substance whenever it is desired to confer specific properties. Thus, the product according to the invention is included in the composition of capsules, capsules, tablets, tablets, gels, aqueous solutions, granules whose formula, without the example being limiting, is for one capsule of 300 mg. Example 1: - coated microgranules 200 mg - acerola powder 50 mg - spirulina powder 25 mg - caffeine 25 mg - coated microgranules 200 mg - acerola powder 50 mg - Muira puama root powder 20 mg - green tea powder 30 mg - coated microgranules 200 mg - richia grandis bark powder 50 mg - turmeric 25 mg - ginger 25 mg Example 4: - coated microgranules 200 mg - acerola powder 50 mg - lactobacillus plantarum 15 mg - lactobacillus acodiphyllus 20 mg 30 - bifido bacterium 15 mg
Exemple 5 : - microgranules enrobés 200 mg - poudre d'acérola 50 mg 35 - guarana 25 mg - spiruline 25mg Exemple 3 40 Example 5: coated microgranules 200 mg - acerola powder 50 mg - guarana 25 mg - spirulina 25 mg Example 3 40
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905770A FR2953103B1 (en) | 2009-11-30 | 2009-11-30 | NUTRITIONAL NUTRITIONAL COMPLEMENT FOR LAND COMPOSED OF MICRO-GRANULES OF MARINE ARAGONITE COATED WITH LYCIUM BARBARUM AND CHINENSE LYCIUM AGGLOMERATED POWDER |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905770A FR2953103B1 (en) | 2009-11-30 | 2009-11-30 | NUTRITIONAL NUTRITIONAL COMPLEMENT FOR LAND COMPOSED OF MICRO-GRANULES OF MARINE ARAGONITE COATED WITH LYCIUM BARBARUM AND CHINENSE LYCIUM AGGLOMERATED POWDER |
| FR0905770 | 2009-11-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2953103A1 true FR2953103A1 (en) | 2011-06-03 |
| FR2953103B1 FR2953103B1 (en) | 2018-05-11 |
Family
ID=42246116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0905770A Active FR2953103B1 (en) | 2009-11-30 | 2009-11-30 | NUTRITIONAL NUTRITIONAL COMPLEMENT FOR LAND COMPOSED OF MICRO-GRANULES OF MARINE ARAGONITE COATED WITH LYCIUM BARBARUM AND CHINENSE LYCIUM AGGLOMERATED POWDER |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2953103B1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2968169A1 (en) * | 2010-12-06 | 2012-06-08 | Steeve Camprasse | Biological response modifying nutritional supplement, comprises marine aragonite microgranules coated with a freeze-dried jelly of Lycium barbarum or Lycium chinense berry |
| CN102697038A (en) * | 2012-05-29 | 2012-10-03 | 宁夏农林科学院 | Medlar bee pollen tablet |
| CN103005449A (en) * | 2013-01-14 | 2013-04-03 | 王跃进 | Medlar soft capsule enriched nutriment |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001084963A1 (en) * | 2000-05-11 | 2001-11-15 | Pharma Futura | Edible composition containing micronised nacre powder |
| CN101112492A (en) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | Chinese traditional medicine preparations for treating diabetic hypertension |
| CN101401875A (en) * | 2008-11-19 | 2009-04-08 | 宁阳根 | Proprietary Chinese medicine for reducing blood pressure |
-
2009
- 2009-11-30 FR FR0905770A patent/FR2953103B1/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001084963A1 (en) * | 2000-05-11 | 2001-11-15 | Pharma Futura | Edible composition containing micronised nacre powder |
| CN101112492A (en) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | Chinese traditional medicine preparations for treating diabetic hypertension |
| CN101401875A (en) * | 2008-11-19 | 2009-04-08 | 宁阳根 | Proprietary Chinese medicine for reducing blood pressure |
Non-Patent Citations (2)
| Title |
|---|
| ANONYMOUS: "Finding Herbal Alternatives to bear bile", 1 January 2006 (2006-01-01), pages 1 - 66, XP002588593, Retrieved from the Internet <URL:http://www.wspa-usa.org/download/144_findingherbalalternativestobearbilev3.pdf> [retrieved on 20100623] * |
| GRANT VINNING: "Medicinal herbs: A compendium", 1 September 2004 (2004-09-01), pages 1 - 12, XP002588594, Retrieved from the Internet <URL:http://www.trade.gov.bt/administration/mktbriefs/10.pdf> [retrieved on 20100623] * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2968169A1 (en) * | 2010-12-06 | 2012-06-08 | Steeve Camprasse | Biological response modifying nutritional supplement, comprises marine aragonite microgranules coated with a freeze-dried jelly of Lycium barbarum or Lycium chinense berry |
| CN102697038A (en) * | 2012-05-29 | 2012-10-03 | 宁夏农林科学院 | Medlar bee pollen tablet |
| CN103005449A (en) * | 2013-01-14 | 2013-04-03 | 王跃进 | Medlar soft capsule enriched nutriment |
| CN103005449B (en) * | 2013-01-14 | 2014-07-16 | 王跃进 | Medlar soft capsule enriched nutriment |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2953103B1 (en) | 2018-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101059482B1 (en) | Method for producing BAA by fermentation of seaweed | |
| CA2386960C (en) | Method for preparing a composition by mother-of-pearl extraction, comprising the mother-of-pearl integral components, composition obtained by said method and it's use in cosmetic and dermatology | |
| TW201536341A (en) | Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging | |
| FR2953103A1 (en) | Metabolism modifying nutritional supplement, useful in the formulation of e.g. gel capsules, tablets, lozenges, gels, and granules, comprises powder of Lycium barbarum and Lycium chinense berry coating microgranules of marine aragonite | |
| CA2821219A1 (en) | Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof | |
| JP6741280B2 (en) | Composition used for ACE inhibition, suppression of blood pressure increase, or blood pressure reduction, and method for producing the same | |
| FR3040881A1 (en) | PROCESS FOR OBTAINING A CONCENTRATE OF MARINE MINERALS | |
| FR2912288A1 (en) | FOOD SUPPLEMENT COMPRISING SPIRULINA AND A PLANT PRODUCT OF THE GENUS ALOE, AND COSMETIC USE THEREOF | |
| EP1652435B1 (en) | Use of red algae subjected to extreme temperature and light conditions. | |
| WO2004071519A1 (en) | Photosynthetic micro-organisms enriched with biologically-active molecules, preparation method thereof and uses of same | |
| FR2827301A1 (en) | Enriching photosynthetic microorganisms with biologically active molecules, useful for delivering pharmaceuticals, by incubating cells in presence of the molecules | |
| WO2020260500A1 (en) | Combination product for helping maintain the natural defenses of the organism | |
| JP5311364B2 (en) | Anti-inflammatory composition | |
| WO2020083923A2 (en) | Composition for treating overweight and/or obesity | |
| WO2020260506A1 (en) | Combination product for helping maintain the natural defenses of the organism | |
| RU2778480C1 (en) | Method for obtaining biologically active substance from oyster crassostrea gigas | |
| KR20160007744A (en) | Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis | |
| FR2968169A1 (en) | Biological response modifying nutritional supplement, comprises marine aragonite microgranules coated with a freeze-dried jelly of Lycium barbarum or Lycium chinense berry | |
| FR2950361A1 (en) | Preparing a hydrolyzate of viscera of marine animals, useful as food supplement, comprises mixing coproducts of marine animals, heating the mixture, adjusting pH, enzymatically hydrolyzing the mixture, heating the hydrolyzate and cooling | |
| WO2024133379A1 (en) | Method for the preparation of a cyanobacteria extract comprising phycocyanin enriched in trace elements from natural trace element sources for the production of food supplements | |
| FR2527424A1 (en) | FOOD AND MANUFACTURING METHOD | |
| Khrychov et al. | PROSPECTS OF USING BROCCOLI CABBAGE AS A SOURCE OF BIOLOGICALLY ACTIVE SUBSTANCES | |
| CN105192701A (en) | Sturgeon compound preparation and preparation process thereof | |
| TWM537906U (en) | Compound particle structure | |
| CN101336724B (en) | Health food for resisting oxidation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| PLFP | Fee payment |
Year of fee payment: 8 |
|
| PLFP | Fee payment |
Year of fee payment: 9 |
|
| CA | Change of address |
Effective date: 20180709 |
|
| PLFP | Fee payment |
Year of fee payment: 11 |
|
| PLFP | Fee payment |
Year of fee payment: 12 |
|
| PLFP | Fee payment |
Year of fee payment: 13 |
|
| PLFP | Fee payment |
Year of fee payment: 14 |
|
| PLFP | Fee payment |
Year of fee payment: 15 |
|
| PLFP | Fee payment |
Year of fee payment: 16 |
|
| TP | Transmission of property |
Owner name: LE JOYAU DE LA MER, FR Effective date: 20250102 |